Olinvacimab

Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer.
Read more
€0.00 (tax incl.)
Reference:
HY-P99768
Product Details
HY-P99768

Data sheet

Size
Multiple sizes
Reactivity
VEGFR
CAS
2095504-49-5

Menu

Settings